Poly Medicure Limited
Symbool: POLYMED.NS
NSE
1585.05
INRMarktprijs vandaag
61.3484
Koers/Winst Verhouding
311.8541
Koers/Winst Groei Verhouding
152.12B
MRK Kapitalisatie
- 0.00%
DIV Rendement
Poly Medicure Limited (POLYMED-NS) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 3090.3 | 3516.7 | 3742.7 | |||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 3019.7 | 3439.1 | 3693.1 | |||||||||||||||||
balance-sheet.row.net-receivables | 0 | 2357.3 | 2403.3 | 1884.5 | |||||||||||||||||
balance-sheet.row.inventory | 0 | 2086.5 | 1683.6 | 1264.8 | |||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 535.9 | 230.7 | 165.8 | |||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 8070.1 | 7834.4 | 7057.8 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 6623.8 | 4769.7 | 3910.2 | |||||||||||||||||
balance-sheet.row.goodwill | 0 | 285.8 | 285.8 | 285.8 | |||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 215.5 | 220.7 | 228.3 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 501.3 | 506.6 | 514.1 | |||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 89.7 | 204.2 | 508.6 | |||||||||||||||||
balance-sheet.row.tax-assets | 0 | 109.1 | 453.6 | 165.5 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 378.1 | 0 | 81.1 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 7702 | 5934 | 5179.5 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 0 | 15772.1 | 13768.3 | 12237.3 | |||||||||||||||||
balance-sheet.row.account-payables | 0 | 923.1 | 890.4 | 645.2 | |||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 1301.7 | 882 | 721.8 | |||||||||||||||||
balance-sheet.row.tax-payables | 0 | 8.4 | 0 | 7.1 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 188.5 | 385.1 | 652.4 | |||||||||||||||||
Deferred Revenue Non Current | 0 | 27.4 | 35.3 | 43.3 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 328.5 | 230.7 | 0 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 422.8 | 626.8 | 867.6 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 25.8 | 14.3 | 32.9 | |||||||||||||||||
balance-sheet.row.total-liab | 0 | 3355.8 | 2893.5 | 2581.6 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 0 | 479.7 | 479.5 | 479.4 | |||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 5277.5 | 3990.4 | 3041.7 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 2730.4 | 2486.2 | 2216.2 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 3928.7 | 3918.7 | 3918.5 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 12416.3 | 10874.8 | 9655.7 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 15772.1 | 13768.3 | 12237.3 | |||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-equity | 0 | 12416.3 | 10874.8 | 9655.7 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||
Total Investments | 0 | 189.7 | 286 | 578.3 | |||||||||||||||||
balance-sheet.row.total-debt | 0 | 1490.2 | 1267.1 | 1374.3 | |||||||||||||||||
balance-sheet.row.net-debt | 0 | 1419.5 | 1189.5 | 1324.7 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 2374.9 | 1952.4 | 1800.5 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 571.7 | 539.5 | 475.2 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -602 | -623.2 | -530.3 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 19.3 | 9.3 | 6.5 | |||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -499.6 | -633.9 | -611.9 | |||||||||||||||||
cash-flows.row.account-receivables | 0 | -288 | -507.4 | -332.3 | |||||||||||||||||
cash-flows.row.inventory | 0 | -402.9 | -418.8 | -143.9 | |||||||||||||||||
cash-flows.row.account-payables | 0 | 37.7 | 247 | 0.6 | |||||||||||||||||
cash-flows.row.other-working-capital | 0 | 153.6 | 45.2 | -136.3 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 44 | -9.5 | 47.2 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -2392.7 | -1555.8 | -951.3 | |||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 1.5 | 15.1 | 6.1 | |||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -579.1 | -660.6 | -3444.3 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 577.6 | 645.4 | -6.1 | |||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 602.6 | 702.5 | 39.8 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -1790.2 | -853.3 | -4355.8 | |||||||||||||||||
cash-flows.row.debt-repayment | 0 | -209.9 | -62.8 | -664.5 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 3.5 | 1 | 4000 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -209.9 | 62.8 | 0 | |||||||||||||||||
cash-flows.row.dividends-paid | 0 | -239.7 | -239.2 | 0 | |||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 531 | -115.2 | -166 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -125.1 | -353.4 | 3169.5 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -7 | 28 | 1 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 70.6 | 77.6 | 49.5 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 77.6 | 49.5 | 48.6 | |||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 1908.3 | 1234.7 | 1187.3 | |||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -2392.7 | -1555.8 | -951.3 | |||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -484.5 | -321.1 | 236 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 11152.3 | 9168.9 | 7750.4 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 4058.8 | 4332.3 | 3364.6 | |||||||||||||||||
income-statement-row.row.gross-profit | 0 | 7093.6 | 4836.6 | 4385.7 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | 0 | 361.9 | 35.5 | 12.3 | |||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 5011.4 | 3195 | 2683.1 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 9070.1 | 7527.3 | 6047.8 | |||||||||||||||||
income-statement-row.row.interest-income | 0 | 59.7 | 22.9 | 33.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 0 | 88.4 | 37.2 | 77.4 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 287.4 | 356.2 | 132 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 361.9 | 35.5 | 12.3 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 287.4 | 356.2 | 132 | |||||||||||||||||
income-statement-row.row.interest-expense | 0 | 88.4 | 37.2 | 77.4 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 571.7 | 539.5 | 475.2 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | 0 | 2087.5 | 1596.2 | 1668.6 | |||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 2374.9 | 1952.4 | 1800.5 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 582.1 | 487.4 | 441.8 | |||||||||||||||||
income-statement-row.row.net-income | 0 | 1792.8 | 1465.1 | 1358.7 |
Vaak gestelde vragen
Wat is Poly Medicure Limited (POLYMED.NS) totale activa?
Poly Medicure Limited (POLYMED.NS) totale activa is 15772092000.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is N/A.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.650.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is 0.191.
Wat is de totale omzet van de onderneming?
De totale opbrengst is 0.248.
Wat is Poly Medicure Limited (POLYMED.NS) nettowinst (netto-inkomen)?
De nettowinst is 1792825000.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 1490168000.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 5011373000.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 0.000.